CASE STUDY

Scaling up a new process to create synthetic DNA

CPI helped Touchlight to scale-up their cell-free dbDNA process, grow their business and secure £147m private investment.

6 February 2023

CASE STUDY

Vaccine taskforce

The UK’s vaccine programme has been vital in combatting COVID-19. In April 2020, CPI joined the UK Government’s Vaccine Taskforce to support the manufacture and formulation of novel mRNA vaccine candidates in the fight against the virus.

3 February 2022

CASE STUDY

Attracting global firms to Renfrewshire

Forging new relationships with both industrial leaders and local communities alike, HVM Catapult’s presence in Renfrewshire is bringing tangible benefits to the region and Scotland as a whole.

3 February 2022